Attivare Therapeutics
PrivateLast Round
Grant
Dec 15, 2025
Total Funding Raised
$12.6M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Attivare Therapeutics operates in Healthcare & Life Sciences and is based in Natick, Massachusetts. Its latest recorded funding round was a Grant round in December 2025.
Attivare Therapeutics is a biotechnology company that develops personalized immunotherapies and vaccine platforms using a proprietary biomaterial scaffold technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Attivare Therapeutics Comparables
Compare Attivare Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| DoriNano | 84% | |
| Corner Therapeutics | 83% | |
| SURGE Therapeutics | 82% |
For institutional investors. Book with your work email.
Attivare Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 15, 2025 | ||||
| Seed | Dec 2, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Attivare Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SymBiosis Capital Management | Seed |
| Embark Ventures | Seed |
| Gaingels | Seed |
| AAF Management | Seed |
| Bill & Melinda Gates Foundation | Grant |
| Ulu Ventures | Seed |
| 8VC | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 48% MoM.
- Dec 15, 2025
Received $7M from the Bill & Melinda Gates Foundation.
For institutional investors. Book with your work email.
Attivare Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Attivare Therapeutics's valuation, stock price, and market status.
Is Attivare Therapeutics a public or private company?
Attivare Therapeutics is a private company.
What is the current stock price of Attivare Therapeutics?
Attivare Therapeutics is a private company, so its shares have no public market price. Caplight tracks Attivare Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Attivare Therapeutics worth (valuation)?
Valuation information for Attivare Therapeutics is not publicly available.
Can I buy Attivare Therapeutics stock?
Attivare Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Attivare Therapeutics's last funding round?
Attivare Therapeutics's most recent funding round was Grant on December 15, 2025.
Who are the main investors in Attivare Therapeutics?
Key investors in Attivare Therapeutics include FundRx.
Will Attivare Therapeutics IPO soon?
No public IPO plans have been announced for Attivare Therapeutics.
How can I track Attivare Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Attivare Therapeutics's shares on secondary markets.